California’s Medicaid program spent the most of all states on GLP-1 coverage, exceeding $1.4 billion, or $118 per enrollee.

The Food and Drug Administration on Friday approved Eli Lilly’s weight-loss drug Zepbound to treat sleep apnea, a common but ...

GLP-1 receptor agonists, which can cost around $1,300 a month, have caused an increase in premiums that “affect all members, ...

The U.S. Food and Drug Administration (FDA) has approved the first prescription medication specifically for treating ...

Connecticut law requires Medicaid to cover certain weight loss drugs, but officials say it hasn't been happening due to cost ...

The U.S. Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Investopedia ranks AARP/UnitedHealthcare as the best Medicare Supplement (Medigap) insurance provider. Other winners include ...

PERSPECTIVES: The resurgence of Y2K skin-baring fashion trends coincides with the rise of prescription weight loss drugs like ...

Lilly investors got the jitters, saw better opportunities elsewhere, or decided to hold onto their chips. In the third ...

From Philly and the Pa. suburbs to South Jersey and Delaware, what would you like WHYY News to cover? While there are some state and federal efforts to expand insurance coverage for these drugs in ...

Zepbound is the first prescription drug approved specifically to treat the common condition. The Food and Drug Administration ...